A detailed history of Tillman Hartley LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Tillman Hartley LLC holds 618 shares of LLY stock, worth $548,135. This represents 0.19% of its overall portfolio holdings.

Number of Shares
618
Previous 618 -0.0%
Holding current value
$548,135
Previous $481 Million 16.38%
% of portfolio
0.19%
Previous 0.17%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023

BUY
$350.74 - $468.98 $12,275 - $16,414
35 Added 6.0%
618 $290 Million
Q4 2022

Feb 22, 2023

BUY
$321.55 - $374.67 $187,463 - $218,432
583 New
583 $213 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $843B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tillman Hartley LLC Portfolio

Follow Tillman Hartley LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tillman Hartley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tillman Hartley LLC with notifications on news.